New study led by Queen Mary University of London finds no evidence that e-cigarettes act as a gateway to smoking at the population level. The research also suggests that alternative nicotine products may be competing against cigarettes, potentially accelerating the decline in smoking, although more data is needed for confirmation.
MPP signs on four generics makers to make Novartis’ Tasigna more accessible
The Medicines Patent Pool has set up sublicense agreements with four manufacturers to produce generic versions of Novartis’ cancer drug Tasigna, as part of an
June 23, 2023